Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LINC Rollover Study of Osilodrostat in Cushing's Syndrome
NCT03606408Phase 2Completed
- Sponsor
- Recordati SpA
- Start
- Oct 2018
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 2 trial of osilodrostat in Cushing's syndrome, sponsored by Recordati SpA. Started Oct 2018; status: completed.
02
Drugs
osilodrostat
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on NCT03606408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03606408.